Osteonecrosis of the jaw and bevacizumab therapy

MeSH terms

• Angiogenesis Inhibitors / adverse effects*
• Angiogenesis Inhibitors / therapeutic use
• Antibodies, Monoclonal / adverse effects*
• Antibodies, Monoclonal / therapeutic use
• Antibodies, Monoclonal, Humanized
• Antineoplastic Agents / adverse effects*
• Antineoplastic Agents / therapeutic use
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Bevacizumab
• Breast Neoplasms / complications
• Breast Neoplasms / drug therapy*
• Breast Neoplasms / pathology
• Diphosphonates / adverse effects*
• Drug Synergism
• Female
• Humans
• Incidence
• Jaw Diseases / chemically induced*
• Jaw Diseases / epidemiology
• Jaw Diseases / prevention & control
• Multicenter Studies as Topic
• Neoplasm Metastasis
• Osteonecrosis / chemically induced*
• Osteonecrosis / epidemiology
• Osteonecrosis / prevention & control
• Prospective Studies
• Randomized Controlled Trials as Topic